Oligomerix is a biotechnology company dedicated to advancing disease-modifying therapies for neurodegenerative diseases, particularly tauopathies. Through innovative research and development, Oligomerix aims to transform treatment options and improve patient outcomes in the healthcare technology and life sciences sectors.
Specialties
Disease-modifying therapies
Targeting tauopathies
Innovative drug development
Neurodegenerative disease solutions
Healthcare technology advancement
Products & Services
Disease-modifying therapies
Tauopathies treatment
Neurodegenerative disease solutions
Innovative research and development
Healthcare technology advancements
Contact Information
No contact information available
Competitors & Similar Companies(8)
Biogen
Massachusetts, • United States
Eisai
New Jersey, • United States
AC Immune
Vaud, • Switzerland
TauRx
England, • United Kingdom • Biotechnology
Alzheimer's disease treatment, Innovative biotechnology solutions, Patient and caregiver support, Neurodegenerative disease focus, Research and development expertise
Alzheon
Massachusetts, • United States
Cassava Sciences
Alector
California, • United States
Helixmith
News & Media
Search Terms:
oligomerix
Search Topics:
AcquisitionAI: Product LaunchInvestment: Approval FundingProject: Bid and AuctionBusiness ExpansionFinancing and FundraisingInvestmentJoint VentureLeadership Change (CXO)MergerPartnershipProduct LaunchPublic Offering (IPO)RebrandingReorganizationRestructuringValuation
Loading...
Frequently Asked Questions about Oligomerix
Where is Oligomerix located?
The headquarter of Oligomerix is located in West Harrison, New York, United States
Oligomerix belongs to the Healthcare Technology, Biotechnology, Pharmaceuticals, Biotechnology and Life Sciences industry.
What are the specialties of Oligomerix?
Oligomerix specializes in Disease-modifying therapies, Targeting tauopathies, Innovative drug development, Neurodegenerative disease solutions, Healthcare technology advancement.
What products and services is Oligomerix likely to offer?
Oligomerix offers Disease-modifying therapies, Tauopathies treatment, Neurodegenerative disease solutions, Innovative research and development, Healthcare technology advancements.
Who are the competitors of Oligomerix?
Competitors of Oligomerix are Biogen, Eisai, AC Immune, TauRx, Alzheon, Cassava Sciences, Alector, Helixmith.
What does Oligomerix do?
Oligomerix is a biotechnology company dedicated to advancing disease-modifying therapies for neurodegenerative diseases, particularly tauopathies. Through innovative research and development, Oligomerix aims to transform treatment options and improve patient outcomes in the healthcare technology and life sciences sectors.